emtricitabine + rilpivirine hydrochloride + tenofovir alafenamide fumarate · Medicine question

How frequently is nausea listed as an adverse reaction to Emtricitabine/Rilpivirine/Tenofovir Alafenamide Gilead?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Nausea is listed as very common (≥1 in 10) for Emtricitabine/Rilpivirine/Tenofovir Alafenamide Gilead, with adverse reactions tabulated by the highest frequency observed.

Sources for this answer

Emtricitabine/Rilpivirine/Tenofovir Alafenamide Gilead 200 mg/25 mg/25 mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §4.8 Undesirable effects · Version 24Document updated 22 October 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about emtricitabine + rilpivirine hydrochloride + tenofovir alafenamide fumarate